Arrowhead Pharmaceuticals Overview
Arrowhead Pharmaceuticals Target Price
Analysts' 12-month price predictions for ARWR.
Share Price
$16.79
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-11-29 | BernsteinWilliam Pickering | $24 |  42.9% upside |  |
| 2024-11-27 | Loop Capital MarketsKeay Nakae | $60 | 257.4% upside | |
| 2024-09-03 | CitigroupDavid Lebowitz | $27 | 60.8% upside | |
| 2024-07-05 | H.C. WainwrightPatrick Trucchio | $60 | 257.4% upside | |
| 2024-06-05 | Goldman SachsAndrea Tan | $31 | 84.6% upside | |
| 2024-05-30 | RBC CapitalLuca Issi | $50 | 197.8% upside | |
| 2023-02-07 | RBC Capital | $77 | 358.6% upside | |
| 2023-02-07 | Piper Sandler | $52 | 209.7% upside | |
| 2022-12-06 | H.C. Wainwright | $90 | 436% upside | |
| 2022-11-29 | Jefferies | $75 | 346.7% upside | |
| 2022-11-29 | Morgan Stanley | $37 | 120.4% upside | |
| 2022-11-29 | Leerink Partners | $31 | 84.6% upside | |
| 2022-01-19 | Goldman SachsMadhu Kumar | $85 | 406.3% upside | |